Pharmaceutical roots
Dr. H. Akhavan begins a career in the pharmaceutical industry, establishing the experience and relationships that would later shape the group.
Jean Vichar Pharmaceutical Company
Jean Vichar is the development and manufacturing company within an integrated pharmaceutical ecosystem whose roots extend to 1965.
REF. JV-ORG-001WHO WE ARE
Established in 2014, Jean Vichar added dedicated product-development and manufacturing capabilities to a pharmaceutical organization already experienced in international sourcing, registration, trade and market development.
Our work begins with the product and the partner’s objective. We assess the dosage form, formulation, components, process requirements, documentation needs and commercial pathway before defining how a program should move forward. Depending on the project, that path may include formulation support, technology transfer, scale-up, validation, registration support, commercial manufacturing, packaging and coordinated distribution.
Jean Vichar directly supports solid oral dosage forms, metered-dose inhalers and nasal spray systems. Dry powder inhaler capability is available through Lirok Pharma. Together with Aram Pharma and Ti-One, these capabilities form a connected route from sourcing and technical evaluation to manufacturing and domestic delivery.
REF. JV-HIST-002OUR STORY
Dr. H. Akhavan begins a career in the pharmaceutical industry, establishing the experience and relationships that would later shape the group.
Aram Pharma is founded as a dedicated organization for pharmaceutical import, registration, trade, marketing and API relationships.
Jean Vichar is created to build pharmaceutical development and manufacturing into the group’s operating model.
Manufacturing, specialized inhalation technologies and distribution are brought together within a clearer, more integrated pharmaceutical ecosystem.
REF. JV-LEAD-003LEADERSHIP PHILOSOPHY
Pharmaceutical manufacturing depends on disciplined decisions, transparent communication and the willingness to remain accountable through every stage of a product’s lifecycle.
Jean Vichar’s leadership approach reflects decades of experience across pharmaceutical sourcing, registration, commercialization and manufacturing. We believe a credible partner should be clear about what can be supported, what must be verified and what is required before a product can progress.
That approach informs our relationships with API manufacturers, technology owners, pharmaceutical companies and healthcare organizations. The objective is not simply to complete a batch or transaction. It is to establish a reliable operating relationship that can support quality, continuity and responsible growth over time.
REF. JV-VISION-004INTEGRATED PHARMACEUTICAL VISION
The ecosystem exists because no single capability is enough to move a pharmaceutical product from opportunity to reliable supply.
Aram Pharma contributes international sourcing, pharmaceutical trade, registration experience and longstanding API relationships. Jean Vichar provides development, technology-transfer and manufacturing capabilities. Lirok Pharma adds focused dry powder inhaler expertise. Ti-One supports controlled storage, nationwide distribution and delivery to pharmacies and treatment centers.
Each company has a distinct operating role. Their value comes from coordination: fewer disconnected handoffs, clearer accountability and a more continuous pathway for partners seeking to enter or expand within the Iranian pharmaceutical market.
Explore the pharmaceutical ecosystem →REF. JV-ROLE-005JEAN VICHAR'S ROLE
Jean Vichar translates product opportunities into structured development and manufacturing programs.
Review the dosage form, formulation status, API and excipient requirements, device or packaging components, technical documentation and intended market pathway.
Establish responsibilities, development needs, technology-transfer scope, scale-up activities, validation requirements, timelines and decision points.
Move the process into a controlled production environment, supported by documented procedures, quality review and agreed acceptance criteria.
Coordinate packaging, ongoing supply planning, lifecycle changes and, where appropriate, distribution through the group’s broader capabilities.
REF. JV-COMMIT-006OUR COMMITMENT
“Our responsibility is to make quality medicines more accessible while building pharmaceutical capabilities that partners and patients can rely on. That requires long-term investment, disciplined manufacturing and relationships based on trust.”

Whether the opportunity begins with an API, an existing dossier, a technology-transfer program or a new product concept, our team can help determine the appropriate next step.
Contact Jean Vichar